Free product worth Rs 499 on all myUpchar products
New GTN 2.6 Tablet CR (30) is a prescription medicine that is available as a Tablet. Angina are some of its major therapeutic uses. Secondary and off-label uses of New GTN 2.6 Tablet CR (30) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of New GTN 2.6 Tablet CR (30). The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed New GTN 2.6 Tablet CR (30) side effects, there are can be others also. These have been listed below. These side effects of New GTN 2.6 Tablet CR (30) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of New GTN 2.6 Tablet CR (30) is Moderate for pregnant women and Moderate for women who are breastfeeding. Further, the section on New GTN 2.6 Tablet CR (30) related warnings talks about New GTN 2.6 Tablet CR (30)'s effects on the liver, heart and kidney.
New GTN 2.6 Tablet CR (30) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid New GTN 2.6 Tablet CR (30) in conditions like Anemia, Low Blood Pressure (Hypotension). Other contraindications of New GTN 2.6 Tablet CR (30) have been discussed in the sections ahead.
Drug interactions for New GTN 2.6 Tablet CR (30) have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that New GTN 2.6 Tablet CR (30) is not safe while driving, and is is not addictive in nature.
New GTN 2.6 Tablet CR (30) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of New GTN 2.6 Tablet CR (30) safe for pregnant women?
Pregnant women may experience moderate side effects from New GTN. It is best to stop taking New GTN immediately and inform your doctor if you notice any discomfort.
Is the use of New GTN 2.6 Tablet CR (30) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of New GTN. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of New GTN 2.6 Tablet CR (30) on the Kidneys?
There are no side effects of New GTN on the kidneys.
What is the effect of New GTN 2.6 Tablet CR (30) on the Liver?
New GTN is rarely harmful for the liver.
What is the effect of New GTN 2.6 Tablet CR (30) on the Heart?
Side effects of New GTN rarely affect the heart.
If you are suffering from any of the following diseases, you should not take New GTN 2.6 Tablet CR (30) unless your doctor advises you to do so -
Is this New GTN 2.6 Tablet CR (30) habit forming or addictive?
New GTN 2.6 Tablet CR (30) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking New GTN 2.6 Tablet CR (30). So it is best to avoid driving.
Is it safe?
New GTN 2.6 Tablet CR (30) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, New GTN 2.6 Tablet CR (30) is not used to treat mental disorders.
Interaction between Food and New GTN 2.6 Tablet CR (30)
You can take New GTN 2.6 Tablet CR (30) with food.
Interaction between Alcohol and New GTN 2.6 Tablet CR (30)
No research has been done on this till date. Therefore, it is not known what the effect of taking New GTN 2.6 Tablet CR (30) with alcohol will be.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 916-917
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 542-543
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nitrostat® (nitroglycerin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gonitro (nitroglycerin)
